Literature DB >> 20015999

Genomewide association analysis of respiratory syncytial virus infection in mice.

James M Stark1, M Michael Barmada, Abby V Winterberg, Nilanjana Majumber, William J Gibbons, Marilyn A Stark, Maureen A Sartor, Mario Medvedovic, Jay Kolls, Kiflai Bein, Beena Mailaparambil, Marcus Krueger, Andrea Heinzmann, George D Leikauf, Daniel R Prows.   

Abstract

Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infection in infants, with about half being infected in their first year of life. Yet only 2 to 3% of infants are hospitalized for RSV infection, suggesting that individual susceptibility contributes to disease severity. Previously, we determined that AKR/J (susceptible) mice developed high lung RSV titers and showed delayed weight recovery, whereas C57BL/6J (resistant) mice demonstrated low lung RSV titers and rapid weight recovery. In addition, we have reported that gene-targeted mice lacking the cystic fibrosis transmembrane conductance regulator (Cftr; ATP-binding cassette subfamily C, member 7) are susceptible to RSV infection. For this report, recombinant backcross and F2 progeny derived from C57BL/6J and AKR/J mice were infected with RSV, their lung titers were measured, and quantitative trait locus (QTL) analysis was performed. A major QTL, designated Rsvs1, was identified on proximal mouse chromosome 6 in both recombinant populations. Microarray analysis comparing lung transcripts of the parental strains during infection identified several candidate genes that mapped to the Rsvs1 interval, including Cftr. These findings add to our understanding of individual RSV susceptibility and strongly support a modifier role for CFTR in RSV infection, a significant cause of respiratory morbidity in infants with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015999      PMCID: PMC2820899          DOI: 10.1128/JVI.00584-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus.

Authors:  Nicole L Kallewaard; Amber L Bowen; James E Crowe
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

2.  Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.

Authors:  Johan Löfgren; Mika Rämet; Marjo Renko; Riitta Marttila; Mikko Hallman
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility.

Authors:  D Hacking; J C Knight; K Rockett; H Brown; J Frampton; D P Kwiatkowski; J Hull; I A Udalova
Journal:  Genes Immun       Date:  2004-06       Impact factor: 2.676

4.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice.

Authors:  F W Henderson; W A Clyde; A M Collier; F W Denny; R J Senior; C I Sheaffer; W G Conley; R M Christian
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

6.  Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection.

Authors:  Beena Puthothu; Marcus Krueger; Johannes Forster; Jessica Heinze; Markus Weckmann; Andrea Heinzmann
Journal:  Pediatr Infect Dis J       Date:  2007-12       Impact factor: 2.129

Review 7.  Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

Authors:  Robert C Welliver
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

8.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

9.  A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.

Authors:  M K Pastey; T L Gower; P W Spearman; J E Crowe; B S Graham
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

10.  Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma.

Authors:  Beena Puthothu; Johannes Forster; Jessica Heinze; Andrea Heinzmann; Marcus Krueger
Journal:  BMC Pulm Med       Date:  2007-05-11       Impact factor: 3.317

View more
  8 in total

1.  Multigenic control and sex bias in host susceptibility to spore-induced pulmonary anthrax in mice.

Authors:  Jagjit S Yadav; Suman Pradhan; Renuka Kapoor; Hansraj Bangar; Benjamin B Burzynski; Daniel R Prows; Linda Levin
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

2.  Toll-like receptor 4-mediated respiratory syncytial virus disease and lung transcriptomics in differentially susceptible inbred mouse strains.

Authors:  Jacqui Marzec; Hye-Youn Cho; Monica High; Zachary R McCaw; Fernando Polack; Steven R Kleeberger
Journal:  Physiol Genomics       Date:  2019-11-18       Impact factor: 3.107

Review 3.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

4.  The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes.

Authors:  Shawn McClelland; Gary P Brennan; Celine Dubé; Seeta Rajpara; Shruti Iyer; Cristina Richichi; Christophe Bernard; Tallie Z Baram
Journal:  Elife       Date:  2014-08-12       Impact factor: 8.140

5.  Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.

Authors:  Waleed Aljabr; Olivier Touzelet; Georgios Pollakis; Weining Wu; Diane C Munday; Margaret Hughes; Christiane Hertz-Fowler; John Kenny; Rachel Fearns; John N Barr; David A Matthews; Julian A Hiscox
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

6.  Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.

Authors:  Monica High; Hye-Youn Cho; Jacqui Marzec; Tim Wiltshire; Kirsten C Verhein; Mauricio T Caballero; Patricio L Acosta; Jonathan Ciencewicki; Zackary R McCaw; Lester Kobzik; Laura Miller-DeGraff; Wes Gladwell; David B Peden; M Elina Serra; Min Shi; Clarice Weinberg; Oscar Suzuki; Xuting Wang; Douglas A Bell; Fernando P Polack; Steven R Kleeberger
Journal:  EBioMedicine       Date:  2016-08-06       Impact factor: 8.143

7.  Inter-individual variation in health and disease associated with pulmonary infectious agents.

Authors:  Kirsten C Verhein; Heather L Vellers; Steven R Kleeberger
Journal:  Mamm Genome       Date:  2018-02       Impact factor: 2.957

Review 8.  Quantitative genetics in the study of virus-induced disease.

Authors:  Martin T Ferris; Mark T Heise
Journal:  Adv Virus Res       Date:  2014       Impact factor: 9.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.